References

Chapin AR, Carpenter CM, Dudley WC, Gibson LC, Pratdesaba R, Torres O, et al. Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler’s diarrhea. J Clin Microbiol. 2005;43(3):1112-1117.

DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent traveler’s diarrhea. Ann Intern Med. 2005;142(10):805-812.

Text Continues Below

---

Ericsson CD. Nonantimicrobial agents in the prevention and treatment of traveler’s diarrhea. Clin Infect Dis. 2005;41 Suppl 8:S557-S563.

Ko G, Garcia C, Jiang ZD, Okhuysen PC, Belkind-Gerson J, Glass RI, et al. Noroviruses as a cause of traveler’s diarrhea among students from the United States visiting Mexico. J Clin Microbiol. 2005;43(12):6126-6129.

Mutsch M, Tavernini M, Marx A, Gregory V, Lin YP, Hay AJ, et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis. 2005;40(9):1282-1287.

Robins GW, Wellington K. Rifaximin: a review of its use in the management of traveller's diarrhoea. Drugs. 2005;65(12):1697-1713.

Wang HH, Shieh MJ, Liao KF. A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults. World J Gastroenterol. 2005;11(10):1540-1543.